|
A Molecular Link between the Active Component of Marijuana and Alzheimer's Disease Pathology |
Eubanks et al. |
| Molecular Pharmaceutics ASAP Article 10.1021/mp060066m |
9/8/06 |
| |
|
A Report of the National Commission on Ganja to the Prime Minister of Jamaica |
Prof. Barry Chevannes, Chairman, et al |
| National Commission on Ganja, Jamaica |
Aug 7, 2001 |
| |
|
Acute effects of smoked marijuana and oral d-9-thc on specific airway conductance in asthmatic subjects |
Tashkin, Shapiro, and Frank |
| American Review of Respiratory Disease, Volume 109, p. 420-428 |
1974 |
| |
|
An endocannabinoid mechanism for stress-induced analgesia |
Hohmann et al. |
| Nature vol 435 p1108-1112 |
23/06/05 |
| |
|
An open-label pilot study of cannabis-based extracts for bladder dysfunction in advanced multiple sclerosis. |
Brady et al. |
| Multiple Sclerosis 10(4):425-33 |
August 2004 |
| |
|
Analgesic and anti-inflammatory activity of constituents of Cannabis Sativa L. |
E.A. Formukong, A.T. Evans, and F.J. Evans |
| Inflammation, Vol 12, No. 4 |
1988 |
| |
|
Anti-Tumor Effects |
GW Pharmaceuticals |
|
|
| |
|
Antiemetic effect of Delta-9-Tetrahydrocannabinol in patients receiving Cancer Chemotherapy |
Sallan, Stephen E., Norman E. Zinberg, and Emil Frei. |
| New England Journal of Medicine Vol. 293(16) 795-797. |
1975 |
| |
|
Antineoplastic activity of cannabinoids |
Munson, Harris, Friedman, Dewey and Carchman |
| Journal of the National Cancer Institute v55 no. 3 |
September 1975 |
| |
|
Anxiety with Depression Research Review |
Edward Glick |
| Oregon Medical Marijuana Act Debilitating Medical Conditions Advisory Panel |
27/03/00 |
| |
|
Are cannabinoids an effective and safe treatment option in the management of pain? A qualitative systematic re |
Campbell et al. |
| British Medical Journal 323(7303):13-6 |
07/07/01 |
| |
|
BMA report calls for change in law and development of new cannabis-based medicines |
|
| British Medical Association |
18/11/97 |
| |
|
Body's 'cannabis' could hold blood pressure key |
|
| BBC Online |
Dec 29, 1998 |
| |
|
Brain chemicals mimic marijuana |
Johnathon S. Choi |
| Reuters |
Aug 1997 |
| |
|
Cannabidiol and D9-tetrahydrocannabinol are neuroprotective antioxidants |
Hampson, Grimaldi, Axelrod and Wink |
| Proceedings of the National Academy of Sciences Vol. 95, pp. 8268–8273 |
July 1998 |
| |
|
Cannabidiol: The Wonder Drug of the 21st Century? |
|
|
|
| |
|
Cannabinoids and Brain Injury |
Mechoulam, Panikashvili, Shohami |
| TRENDS in Molecular Medicine Vol.8 No.2 |
February 2002 |
| |
|
Cannabinoids block release of serotonin from platelets induced by plasma from migraine patients |
Volfe Z., Dvilansky A., Nathan I. |
| Int J Clin Pharm. Res V (4) 243-246 |
1985 |
| |
|
Cannabinoids control spasticity and tremor in a multiple sclerosis model |
David Baker, et al. |
| Nature |
20 Jan 2000 |
| |
|
Cannabinoids for control of chemotherapy induced nausea and vomiting: quantitative systematic review |
Tramer et al. |
| British Medical Journal 2001;323:1–8 |
7/7/01 |
| |
|
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study) |
Zajicek et al. |
| Lancet 2003; 362: 1517–26 |
2003 |
| |
|
Cannabinoids in bipolar affective disorder: a review and discussion of their therapeutic potential |
Ashton et al. |
| Journal of Psychopharmacology, Vol. 19, No. 3, 293-300 |
2005 |
| |
|
Cannabinoids on the Brain |
Andrew J. Irving, Mark G. Rae, Angela A. Coutts |
| TheScientificWorldJOURNAL (2002) 2, 632-648 |
2002 |
| |
|
Cannabinoids promote embryonic and adult hippocampus neurogenesis and produce anxiolytic- and antidepressant-like effects |
Jiang et al. |
| Journal of Clinical Investigation [Electronic publication ahead of print] |
13/10/05 |
| |
|
Cannabinoids: Potential Anticancer Agents |
Manuel Guzman |
| Nature Reviews |
1 Oct 2003 |
| |
|
Cannabis - Government Response |
The House of Lords, Science and Technology Committee |
|
4 March 1999 |
| |
|
Cannabis and schizophrenia: results of a follow-up study |
Dieter Caspari |
| European Archives of Psychiatry and Clinical Neuroscience 249 :45–49 |
1999 |
| |
|
Cannabis and the brain |
Leslie Iversen |
| Brain vol 126 p1252-1270. |
2003 |
| |
|
Cannabis antagonists: a new era of social psychopharmacology? |
Nutt, D. |
| Journal of Psychopharmacology 19(1):3-4. |
January 2005 |
| |
|
Cannabis for migraine treatment: The once and future prescription? An historical and scientific review |
Russo E. |
| Pain 1998;76(1-2):3-8. |
1998 |
| |
|
Cannabis treatments in Obstetrics and Gynecology: A historical review |
Ethan Russo |
| Journal of Cannabis Therapeutics Vol. 2, No. 3/4, p5-35 |
2002 |
| |
|
Cannabis, cannabinoids and reproduction |
Boram Park, John McPartland and Michelle Glass |
| Prostaglandins, Leukotrienes and Essential Fatty Acids 70 189–197 |
2004 |
| |
|
Cannabis: Medical reality versus authoritarian brutality |
Ian Williams Goddard |
|
1996 |
| |
|
Cannabis: The Scientific And Medical Evidence |
The House of Lords, Science and Technology Committee |
|
4 Nov 1998 |
| |
|
Clinical Studies and Case Reports |
|
| International Association for Cannabis as Medicine |
|
| |
|
Control by the endogenous cannabinoid system of ras oncogene-dependent tumor growth |
Maurizio Bifulco et al. |
| Federation of American Societies for Experimental Biology Journal |
29/10/01 |
| |
|
Counterblast to the I.O.M. |
Peter Webster |
| International Journal of Drug Policy |
1999 |
| |
|
Decreased depression in marijuana users |
Denson and Earleywine |
| Addictive Behaviors (electronic publication ahead of print) |
17/06/05 |
| |
|
Delta-9 tetrahydrocannabinol (THC) inhibits lytic replication of gamma oncogenic herpesviruses in vitro |
Medveczky, Sherwood, Klein, Friedman, and Medveczky |
| BMC Medicine 2004, 2:34 |
15/09/04 |
| |
|
Delta-9-tetrahydrocannabinol effects in schizophrenia: implications for cognition, psychosis, and addiction |
D'Souza et al. |
| Biological Psychiatry 15;57(6):594-608 |
March 2005 |
| |
|
Delta-9-Tetrahydrocannibinol as an antiemetic in cancer patients receiving high-dose Methotrexate |
Chang et al. |
| Annals of Internal Medicine 91: 819-824 |
December 1979 |
| |
|
Differential cannabinoid receptor signaling by anandamide directs blastocyst activation for implantation |
Wang, Matsumoto, Guo, Paria, Roberts, Dey |
| Proceedings of the National Academy of Sciences vol 100, no 25, 14914-14919 |
9/12/03 |
| |
|
Differential effects of medical marijuana based on strain and route of administration:A three-year observation |
Valerie Leveroni Corral |
| Wo/Men's Alliance for Medical Marijuana |
2001 |
| |
|
Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? |
Wade et al. |
| Multiple Sclerosis 10(4):434-441 |
August 2004 |
| |
|
Does the cannabinoid dronabinol reduce central pain in multiple sclerosis? |
Svendsen, Jensen, Bach |
| British Medical Journal 329 (7460): 253 |
31/07/04 |
| |
|
Effect of marihuana on intraocular and blood pressure in glaucoma |
Merritt, Crawford, Alexander, Anduze and Gelbart |
| Ophthalmology Vol. 87, No. 3, pp. 222-228 |
March 1980 |
| |
|
Effects of cannabidiol on schizophrenia-like symptoms in people who use cannabis |
Morgan and Curran |
| The British Journal of Psychiatry (2008) 192, 306–307 |
2008 |
| |
|
Effects of cannabis and psychosis vulnerability in daily life: an experience sampling test study |
Verdoux et al. |
| Psychological Medicine, 2003, 33, 23-32. |
2003 |
| |
|
Effects of Smoked Marijuana in Experimentally Induced Asthma |
Tashkin, Shapiro, Lee and Harper |
| American Review of Respiratory Disease, Vol. 112 |
1975 |
| |
|
Efficacy of two cannabis based medicinal extracts for relief of central neuropathic pain from brachial plexus |
Berman, Symonds, Birch |
| Pain 112 (2004) 299–306 |
2004 |
| |
|
Efficacy, safety and tolerability of an...cannabis extract in the treatment of spasticity in...MS |
Vaney et al. |
| Multiple Sclerosis 10(4):417-24 |
August 2004 |
| |
|
Emerging properties of cannabinoid medicines in management of multiple sclerosis. |
Pryce G, Baker D. |
| Trends in Neurosciences 28(5):272-6 |
May 2005 |
| |
|
Endocannabinoid metabolism in human glioblastomas and meningiomas compared to human non-tumour brain tissue |
Petersen et al. |
| Journal of Neurochemistry 93(2):299-309 |
April 2005 |
| |
|
Endocrine Effects of Marijuana |
Todd T. Brown, MD, and Adrian S. Dobs, MD, MHS |
| Journal of Clinical Pharmacology, 2002;42:90S-96S |
2002 |
| |
|
Excerpt from the Merck Manual |
Robert Berkow |
| Merck Manual of Diagnosis and Therapy, 15th edition |
1987 |
| |
|
Familial Predisposition for Psychiatric Disorder - Comparison of Subjects Treated for Cannabis-Induced Psychosis and Schizophrenia |
Arendt, Mortensen, Rosenberg, Pedersen, Waltoft |
| Arch Gen Psychiatry. 2008;65(11):1269-1274 |
2008 |
| |
|
Hemp for headache: An in-depth historical and scientific review of cannabis in migraine treatment |
Russo E. |
| Journal of Cannabis Therapeutics 2001;1(2):21-92. |
2001 |
| |
|
HU308 - A specific agonist for CB2, a peripheral cannabinoid receptor |
L. Hanus et al. |
| Proceedings of the National Academy of Sciences 96:25, 14228-14233 |
07/12/99 |
| |
|
Inhibition of Glioma Growth in Vivo by Selective Activation of the CB2 cannabinoid receptor |
Cristina Sanchez et al. |
| Cancer Research 61, 5784-5789 |
01/08/01 |
| |
|
Inhibition of skin tumor growth and angiogenesis in vivo by activation of cannabinoid receptors |
M. Llanos Casanova et al. |
| Journal of Clinical Investigation 111:43-50 |
2003 |
| |
|
Initial experiences with medicinal extracts of cannabis for chronic pain: Results from 34 'N of 1' studies |
Notcutt, Price, Miller, Newport, Phillips, Simmons and Sansom |
| Anaesthesia, 2004, 59, pp440–452 |
2004 |
| |
|
Is cannabis an anti-antipsychotic? The experience in psychiatric intensive care |
Isaac M, Isaac M, Holloway F |
| Human Psychopharmacology 2005 Apr;20(3):207-10. |
April 2005 |
| |
|
Low dose oral cannabinoid therapy reduces progression of atherosclerosis in mice |
Steffens et al. |
| Nature 434, 782 - 786 |
07/04/05 |
| |
|
Marijauna and the brain part 2: The tolerance factor |
Jon Gettman |
| High Times |
July 1995 |
| |
|
Marijauna and the human brain |
Jon Gettman |
| High Times |
March 1995 |
| |
|
Marijuana - a missed market opportunity? |
Lisa Nainggolan |
| Scrip World Pharmaceutical News |
December 1997 |
| |
|
Marijuana and medicine: Assessing the science base |
Janet E. Joy, Stanley J. Watson, Jr., and John A. Benson, Jr., Editors |
| US Institute of Medicine (IOM) |
1999 |
| |
|
Marijuana as medicine - A recent history (1976-1996) with recommendations |
Robert C. Randall and Alice M. O'Leary |
|
1996 |
| |
|
Marijuana as medicine: A plea for reconsideration |
Lester Grinspoon and James B. Bakalar |
| Journal of the American Medical Association - Vol. 273, No. 23 1875 |
21/06/95 |
| |
|
Marijuana Effects on the Endocrine and Reproductive Systems |
Braude and Ludford |
| NIDA Research Monograph 44 |
1984 |
| |
|
Medical cannabis fact sheets |
|
| The Alliance for Cannabis Therapeutics |
|
| |
|
Medical Marijuana |
Jane B. Marmor |
| Western Journal of Medicine 1998; 168: 540-543 |
1998 |
| |
|
Medicinal cannabis and derivatives |
|
| European Monitoring Centre for Drugs and Drugs Addiction (EMCDDA) |
May 2002 |
| |
|
Mesenteric Vasodilation Mediated by Endothelial Anandamide Receptors |
Jens A. Wagner, Karoly Varga, Zoltan Jarai, George Kunos |
| Hypertension 33(1 Pt 2):429-34. |
January 1999 |
| |
|
Neurons on cannabinoids: dead or alive? |
Manuel Guzman |
| British Journal of Pharmacology 140:439-440 |
2003 |
| |
|
On the pharmaceuticalization of marijuana |
Lester Grinspoon |
| International Journal of Drug Policy Vol 12, 5-6, pp 377-383 |
01/11/01 |
| |
|
Preliminary assessment of the efficacy, tolerability and safety of a cannabis-based medicine (Sativex) in the treatment of pain caused by rheumatoid arthritis |
Blake et al. |
| Rheumatology Advance Access |
9/11/05 |
| |
|
Preliminary study to determine whether whole-plant cannabis extracts improve intractable neurogenic symptoms |
Derick T Wade, Philip Robson, Heather House, Petra Makela and Julia Aram |
| Clinical Rehabilitation 2003; 17: 21–29 |
2003 |
| |
|
Product monograph for Sativex |
|
| GW Pharma Ltd. |
13/04/05 |
| |
|
Proven: Cannabis is safe medicine |
Ian Williams Goddard |
|
1996 |
| |
|
Psychiatric aspects of marihuana intoxication |
Samuel Allentuck and Karl Bowman |
| American Journal of Psychiatry |
September 1942 |
| |
|
Self-change: A pathway to cannabis abuse resolution |
Ellingstad et al. |
| Addictive Behaviors (electronic publication ahead of print) |
18/06/05 |
| |
|
Some cannabis research from 1975 - present |
|
| Medline |
1998 |
| |
|
Study gauges secondhand smoke toll |
|
| San Jose Mercury News |
24/10/97 |
| |
|
Targeting CB2 cannabinoid receptors as a novel therapy to treat malignant lymphoblastic disease |
Robert J. McKallip et al |
| Blood, Vol. 100, No. 2, pp. 627-634 |
15 July 2002 |
| |
|
Tetrahydrocannabinol-induced neurotoxicity depends on CB1 receptor-mediated c-Jun N-terminal kinase activation |
Eric J Downer, Marie P Fogarty and Veronica A Campbell |
| British Journal of Pharmacology 140:547-557 |
2003 |
| |
|
The cannabinoids in MS study – final results from 12 months follow-up |
J. Zajicek |
| Multiple Sclerosis 10 (2004) (Suppl), p. S115. |
September 2004 |
| |
|
The endogenous cannabinoid anandamide inhibits human breast cancer cell proliferation |
De Petrocellis, Melck, Palmisano, Bisogno, Laezza, Bifulco, Di Marzo |
| Proceedings of the National Academy of Sciences 95: 8375-8380 |
July 1998 |
| |
|
The endogenous cannabinoid system protects against colonic inflammation |
Massa F, et al |
| The Journal of Clinical Investigation 113 (8): 1202–1209 |
15/04/04 |
| |
|
The Medical Marijuana Issue Among PWAs: Reports of Therapeutic Use and Attitudes Toward Legal Reform |
Ben Wesner |
| Working Paper Series, University of Hawaii at Minoa |
June 1996 |
| |
|
The nonpsychoactive component of marijuana cannabidiol modulates chemotaxis and IL-10 and IL-12 production... |
Sacerdote P, et al |
| Journal of Neuroimmunology 159(1-2):97-105 |
2005 |
| |
|
The therapeutic potential of cannabis |
Baker, Pryce, Giovannoni, and Thompson |
| The Lancet Neurology Vol 2 p291-298 |
May 2003 |
| |
|
The therapeutic value of cannabinoids in MS: real or imaginary? |
Killestein and Polman |
| Multiple Sclerosis 10(4):339-40. |
August 2004 |
| |
|
The Use of Cannabis as a Mood Stabilizer in Bipolar Disorder |
Lester Grinspoon, M.D. & James B. Bakalar |
| Journal of Psychoactive Drugs |
Apr/Jun 1998 |
| |
|
Therapeutic aspects of cannabis and cannabinoids |
Philip Robson |
| The British Journal of Psychiatry vol. 178 pp. 107-115 |
February 2001 |
| |
|
Therapeutic Potential and Medical Uses of Marijuana |
Tod Mikuriya |
| Journal of Psychoactive Drugs 14: 239-241 |
1982 |
| |
|
Therapeutic Uses Of Cannabis |
The House of Lords, Science and Technology Committee |
|
14 March 2001 |
| |
|
Use of cannabinoids in MS: is it evidence based? |
C. Vaney, Berner Klinik |
| Multiple Sclerosis 2004 10 (suppl 2): 115 |
2004 |
| |
